R-ICE versus R-ESHAP for salvage therapy in aggressive B-cell non-Hodgkin lymphoma.

被引：0
|
作者：
Freyer, Craig [1 ]
George, Timothy [1 ]
Price, Samantha [1 ]
Shah, Bijal Dinesh [1 ]
Bello, Celeste M. [1 ]
Sokol, Lubomir [1 ]
Sotomayor, Eduardo M. [1 ]
Cultrera, Jennifer L. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18509
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of salvage treatment modalities in patients with positive FDG-PET/CT after R-CHOP chemotherapy for aggressive B-cell non-Hodgkin lymphoma
    Chin, Vicky
    Fulham, Michael
    Hertzberg, Mark
    Jackson, Michael
    Lindeman, Robert
    Brighton, Timothy
    Kidson-Gerber, Giselle
    Wegner, Eva A.
    Cheung, Carol
    MacCallum, Susan
    Williams, Janet
    Thompson, Stephen R.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (03) : 432 - 439
  • [42] A PHASE 2B TRIAL COMPARING DACETUZUMAB plus R-ICE VS PLACEBO plus R-ICE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
    Fayad, L.
    Ansell, S. M.
    Advani, R.
    Coiffier, B.
    Bartlett, N. L.
    Stuart, R.
    Forero-Torres, A.
    Kuliczkowski, K.
    Drachman, J. G.
    ANNALS OF ONCOLOGY, 2011, 22 : 132 - 132
  • [43] B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy
    Lei Jiang
    Nailin Li
    Angiogenesis, 2020, 23 : 515 - 529
  • [44] A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
    Witzig, T. E.
    Nowakowski, G. S.
    Habermann, T. M.
    Goy, A.
    Hernandez-Ilizaliturri, F. J.
    Chiappella, A.
    Vitolo, U.
    Fowler, N.
    Czuczman, M. S.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1667 - 1677
  • [45] Emphysematous Gastritis, a Rare Complication in B-Cell Non-Hodgkin Lymphoma After Initiation of R-CHOP Therapy
    Le, M.
    Mohindra, V.
    Gohil, A. A.
    Kirsch, C. M.
    Wu, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
    Zuckerman, T
    Zuckerman, E
    Douer, D
    Fong, TL
    Nathwani, BN
    Velankar, M
    Gutekunst, K
    Qian, GD
    Levine, AM
    BLOOD, 1996, 88 (10) : 877 - 877
  • [47] CD37 Is a Potential Therapeutic Target for B-Cell Non-Hodgkin Lymphoma.
    Zhao, Xiaoxian
    Ybarra, Suzanne
    Durkin, Lisa
    Sho, Mien
    Kumar, Neeraj
    Gordon, Brian
    Algate, Paul
    Starling, Gary
    Chao, Debra
    Hsi, Eric
    BLOOD, 2010, 116 (21) : 1277 - 1278
  • [48] B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy
    Jiang, Lei
    Li, Nailin
    ANGIOGENESIS, 2020, 23 (04) : 515 - 529
  • [49] PHARMACOKINETICS AND DRUG INTERACTION POTENTIAL OF POLATUZUMAB VEDOTIN IN COMBINATION WITH R/G-CHP IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA.
    Shemesh, C. S.
    Agarwal, P.
    Lee, C.
    Dere, R. C.
    Miles, D.
    Li, X.
    Li, C.
    Girish, S.
    Jin, J. Y.
    Lu, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S71 - S71
  • [50] Overview of antibody therapy in B-cell non-Hodgkin's lymphoma
    Wannesson, L
    Ghielmini, M
    CLINICAL LYMPHOMA, 2003, 4 : S5 - S12
12345